Sleep Aids Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. According to Centers for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have trouble focusing due to lack of sleep.

Restraints of the Global Sleeping Aids Market

Major factors hampering the growth of the sleep aids market during the forecast period constitutes of side effects associated with sleep aid medications, and patent expirations of medications.

Key features of the study:

• This report provides in-depth analysis of the global sleeping aids market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global sleeping aids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc., Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global sleeping aids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Sleeping Aids Market, By Product Type:

• Medication
• Sleep laboratories
• Mattresses and pillows
• Sleep apnea devices
• Others

Global Sleeping Aids Market, By Sleep Disorder:

• Insomnia
• Sleep apnea
• Restless legs syndrome
• Narcolepsy
• Night terrors
• Others

Global Sleeping Aids Market, By Geography:

• North America

o By Country:

• U.S.
• Canada
• Europe

o By Country:

• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific

o By Country:

• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America

o By Country:

• Brazil
• Mexico
• Argentina
• Rest of Latin America

o Middle East:

o By Country:

• GCC
• Israel
• Rest of Middle East
• Africa

o By Country/Region:

• Central Africa
• South Africa
• North Africa
• Company Profiles
• Sanofi S.A.*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• Merck & Co., Inc.
• Pfizer, Inc.
• Koninklijke Philips N.V.
• GlaxoSmithKline Plc
• Sommetrics, Inc.
• ResMed Inc.
• Cadwell Laboratories, Inc.
• Therapix Biosciences Ltd.
• SleepMed, Inc.
• Natus Medical Incorporated
• DeVilbiss Healthcare LLC
• Compumedics Limited

“*” marked represents similar segmentation in other categories in the respective section.